Found 1830 clinical trials
27 feb-
Based on the Stage 1 analysis performed in November 2014, Arm 1 was chosen for expansion in Stage 2. Stage 2 dose will be 1-5x10xE8 transduced CART-19 cells. The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% …
- 0 views
- 27 Feb, 2023
- 1 location
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients
An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.
- 0 views
- 16 Feb, 2024
- 9 locations
Characterization of Chewing and Swallowing and Verification of the Effectiveness of Orofacial Motricity Stimulation in Severe Obese Pre and Post Bariatric Surgery: a Randomized Controlled Clinical Trial.
After the initial assessment, patients will be randomly assigned to an intervention group (MOG) and a control group (COG). The COG and MOG groups will be evaluated before and after bariatric surgery.
- 0 views
- 07 Sep, 2022
- 2 locations
Investigation of the Effects of Exercise on Patients With Chiari Malformation
After 6 weeks, the first evaluations will be repeated in both groups.
- 0 views
- 16 Feb, 2024
- 1 location
Analytics Superset testing, please dont change it (CHXLAS)
This Phase 2 randomized controlled trial will study the safety, tolerability, and efficacy of Hydroxychloroquine in qualified patients with Alport syndrome. The trial will be open-label, randomized, controlled and will enroll up to 50 patients.
- 0 views
- 28 Feb, 2024
- 1 location
Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (Acronym)
This Phase 2 randomized controlled trial will study the safety, tolerability, and efficacy of Hydroxychloroquine in qualified patients with Alport syndrome. The trial will be open-label, randomized, controlled and will enroll up to 50 patients.
- 0 views
- 08 Mar, 2024
- 2 locations
A Multicentre Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
This study is to see if the standard of care subcutaneous injection of bortezomib can safely be administered at home by the patient or caregiver. All tests and assessments are based on standard of care procedures.
- 0 views
- 16 Feb, 2024
- 1 location
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes
Participants will get once daily injections of either NNC0472-0147 or insulin glargine for a treatment period of fourteen days. The injections will be given under the skin (subcutaneously, s.c.) of the left thigh. Participants will be in the study for about 7 weeks. There will be 15 visits with the …
- 0 views
- 16 Feb, 2024
- 2 locations
Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness and Parental Substance Use
Our primary hypothesis is that the adapted family resilience program will be feasible and acceptable to families with a recent history of homelessness and parental substance use disorder. Families that are eligible to participate in the study will be assigned randomly to one of two groups, 1) adapted family resilience …
- 0 views
- 16 Feb, 2024
- 1 location
Mobile App as a Guide to Exercises for Patients With Chronic Stroke
Even if chronicity leads us to think about the stabilization of the physical condition, It is thought that the best results will be found among the subjects who will use the App.
- 0 views
- 16 Feb, 2024
- 1 location